Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
73.63%
↑ 126% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-284.99%
Historical baseline
PeriodValue
202573.63%
202431.22%
2023-148.29%
2022-1666.60%
2021114.64%
2020-461.17%
2019-223.36%
20180.00%